News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Onsite contraceptive services curb unintended pregnancies in women with opioid use disorder
By Marilynn Larkin NEW YORK (Reuters Health) - For women with opioid use disorder (OUD) at risk for unintended pregnancy, onsite contraceptive services are likely more effective than usual care, but
Success rates for coronary re-access after TAVR higher in patients with short stent-frame prostheses
By Marilynn Larkin NEW YORK (Reuters Health) - Acute coronary syndrome (ACS) patients who have undergone transcatheter aortic valve replacement (TAVR) may still undergo coronary angiography (CA) or
Vector-based vaccines likely more effective in patients on rituximab
By Marilynn Larkin NEW YORK (Reuters Health) - In patients treated with B cell-depleting rituximab, vector-based vaccines that don't induce a type 1 interferon (IFN-1) response will likely enable a
Genes have role in common-cold protection against COVID-19
By Reuters Staff (Reuters) - In some people, past exposure to common-cold coronaviruses seems to prepare the immune system to fight the COVID-19 coronavirus, but it has not been clear why this is not
Separate unvaccinated healthcare staff from unvaccinated patients, researchers advise
By Reuters Staff (Reuters) - With COVID-19 vaccination coverage incomplete among residents and staff at long-term care facilities, researchers have come up with a way to limit transmission in those
Wearable warning device reduces collisions for the blind and visually impaired
By Linda Carroll (Reuters Health) - A wearable computerized vision device may reduce collisions among blind and visually impaired people who use a long cane and/or guide dog, a new study suggests. In
Even low lead levels in drinking water tied to worse kidney disease outcomes
By Lisa Rapaport (Reuters Health) - Kidney disease patients may have lower hemoglobin levels and take higher doses of medication to treat anemia when they're exposed to lead in their drinking water,
EXCLUSIVE-'QAnon Shaman' in plea negotiations after mental health diagnosis -lawyer
By Sarah N. Lynch WASHINGTON (Reuters) - The participant in the Jan. 6 U.S. Capitol riots nicknamed the "QAnon Shaman" is negotiating a possible plea deal with prosecutors, after prison psychologists
Progressive rehabilitation improves outcomes for elderly heart failure patients
By Lisa Rapaport (Reuters Health) - Older adults hospitalized for heart failure may have greater improvements in physical function when they receive progressive rehabilitation focused on strength,
FOCUS-White House sees YouTube, Facebook as 'Judge, Jury & Executioner' on vaccine misinformation
By Nandita Bose WASHINGTON (Reuters) - The White House has YouTube, not just Facebook, on its list of social media platforms officials say are responsible for an alarming spread of misinformation
WHO urges collaboration on virus origin after China rejects inquiry plan
By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) called on Friday for all countries to work together to investigate the origins of the coronavirus that caused COVID-19, a
Dispute over Italian coronavirus study shows challenges of probing origins
By Emilio Parodi MILAN (Reuters) - A dispute over blood tests has raised questions about an Italian study that suggested the coronavirus was circulating outside China much earlier than expected,
Blistering eruptions, including bullous pemphigoid, seen after COVID vaccine
By Reuters Staff NEW YORK (Reuters Health) - SARS-CoV-2 mRNA vaccines may trigger subepidermal blistering eruptions, particularly bullous pemphigoid and most often in older adults, U.S. clinicians
Vaccinated people make up 75% of recent COVID-19 cases in Singapore, but few fall ill
By Aradhana Aravindan and Chen Lin SINGAPORE (Reuters) - Vaccinated individuals accounted for three-quarters of Singapore's COVID-19 infections in the last four weeks, but they were not falling
Want a bigger raise? How about $50? U.S. companies push COVID shots for staff
By Timothy Aeppel and Ben Klayman (Reuters) - Kevin Kelly is hitting his anti-vax workers where it may hurt them most: their paychecks. On Sept. 1, when regular raises go through for the 250 workers
T. gondii seropositivity tied to mild cognitive impairment
By David Douglas NEW YORK (Reuters Health) - In otherwise healthy people quiescent infection with Toxoplasma gondii may be associated with impairment in certain areas of cognitive function, according
American Board of Surgery's first virtual certifying exam a huge success
By Reuters Staff NEW YORK (Reuters Health) - The first virtual certifying exam (CE) by the American Board of Surgery (ABS) was met with high marks from the general-surgery trainees who took it, with
Gut-microbiome changes may precede celiac disease onset in at-risk children
By Reuters Staff NEW YORK (Reuters Health) - Changes in the gut microbiome appear to precede the onset of celiac disease (CD) in at-risk children, a new study suggests. "We found significant changes
Urinary thromboxane B2 may be marker of aggressive prostate cancer in Black men
By Reuters Staff NEW YORK (Reuters Health) - Upregulation of urinary thromboxane B2 may be a new marker of aggressive prostate cancer in African American men, a group that bears a disproportionately
As Americans navigate conflicting COVID-19 mask advice, 'everyone is confused'
By Joseph Ax and Tim Reid PRINCETON, N.J./SANTA MONICA, Calif. (Reuters) - A COVID-19 surge ignited in parts of the United States by the highly contagious Delta variant and vaccine hesitancy has led
Living-donor transplants could improve survival for liver cancer patients
By Marilynn Larkin NEW YORK (Reuters Health) - Having a potential live donor could decrease deaths among liver cancer patients on a transplant waiting list by reducing the dropout risk, researchers
Parts of Europe raise defences and push vaccines as Delta advances
By Crispian Balmer ROME (Reuters) - Looking to counter the increasing menace of the coronavirus Delta variant, a growing number of European countries are raising their defences and trying to pressure
Spacing Pfizer COVID shots boosts antibody levels in long-term study
By Reuters Staff LONDON (Reuters) - A longer gap between doses of Pfizer's COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but antibody
Moderna COVID-19 vaccine gets EU regulator endorsement for teens
By Pushkala Aripaka (Reuters) - Moderna's COVID-19 vaccine could become the second shot okayed for adolescent use in the European Union after regulators on Friday recommended approving it for 12- to
Sinopharm's COVID-19 shot offers weaker protection among elderly - study
By Reuters Staff (Reuters) - Sinopharm's COVID-19 vaccine was less effective in offering protection against the disease among the elderly, according to the results of a Hungarian study. The study of
Study tracks COVID-19 spread in households after camp outbreak
By Reuters Staff (Reuters Health) - A new look at how COVID-19 spreads in households has concluded that the disease can easily be passed to parents and extended family members, but social distancing
BMI association with diabetes risk varies across low- and middle-income countries
By Lisa Rapaport (Reuters Health) - The optimal BMI threshold for diabetes screening may vary across low- and middle-income countries, results from a new study of the association between BMI and
UPDATE 1-UK to launch daily COVID tests in food sector to tackle 'pingdemic'
(Adds plan to roll out daily testing) By Guy Faulconbridge and James Davey LONDON (Reuters) - Daily contact testing will be rolled out to workplaces in Britain's food sector so staff who have been '
Combination therapy shows promise in oligorecurrent pelvic-node relapses of prostate cancer
By Reuters Staff NEW YORK (Reuters Health) - The combination of high-dose salvage pelvic radiotherapy and six months of androgen-deprivation therapy (ADT) shows promise for oligorecurrent pelvic nodal
Mississippi asks U.S. Supreme Court to overturn abortion rights landmark
By Lawrence Hurley WASHINGTON (Reuters) - The state of Mississippi on Thursday urged the U.S. Supreme Court in a major case set to be argued in its next term to overturn the landmark 1973 ruling that
Physical activity tied lower all-cause mortality after ICD implantation
By Lisa Rapaport (Reuters Health) - Older patients with implanted cardioverter defibrillators (ICDs) are at lower risk of heart failure hospitalization and all-cause mortality when they get more
Remote monitoring of chemotherapy patients may help optimize care at home
By Linda Carroll (Reuters Health) - Chemotherapy patients who receive remote 24-hour monitoring may have better quality of life and better control of symptoms compared to those who receive standard
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
By Reuters Staff (Reuters) - Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks
Systemic and structural racism present in U.S. neonatal intensive-care units
By Reuters Staff NEW YORK (Reuters Health) - Quality of care across and within neonatal intensive-care units (NICUs) in the United States varies by race and ethnicity, according to a new study that
U.S. senators aim to stop vaccine misinformation by going after tech's legal immunity
By Reuters Staff WASHINGTON (Reuters) - Two Democratic U.S. senators on Thursday will add to the stack of bills going after Section 230 - a law that protects tech companies from being sued over
German pharmacies stop issuing COVID vaccine passes after security breach
By Reuters Staff BERLIN (Reuters) - German pharmacies have stopped issuing digital COVID-19 vaccination certificates after hackers created passes from fake outlets, the industry association said on
UPDATE 1-China rejects WHO plan for study of COVID-19 origin
(Adds White House reaction, paragraph 12) By Gabriel Crossley BEIJING (Reuters) - China rejected on Thursday a World Health Organization (WHO) plan for a second phase of an investigation into the
India's DNA data law seen to harm minorities, hurt privacy
By Rina Chandran (Thomson Reuters Foundation) - A proposed Indian law on the collection and use of genetic data to tackle crime can violate privacy, and target minorities and marginalised communities
Virtual roller coaster tied to dizziness, motion sickness in migraine patients
By Lisa Rapaport (Reuters Health) - People who get migraines are more likely than others to experience dizziness and motion sickness from a virtual reality roller coaster and show different associated
CDC guidance on masking unchanged as Delta variant sweeps U.S. - Walenksy
By Carl O'Donnell and Jeff Mason (Reuters) - The U.S. Centers for Disease Control and Prevention has not revised its masking guidance, even as the infectious Delta variant of COVID-19 continues to
Antibiotic-resistant pneumonia quickly killing Bangladeshi children
By Ronnie Cohen (Reuters Health) - Seven years ago, Dr. Mohammod Jobayer Chisti noticed a disturbing trend among young children he treated with standard antibiotics for pneumonia at the International
CDC advisers consider boosters for immune-compromised Americans
By Julie Steenhuysen CHICAGO (Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention on Thursday will consider evidence suggesting that a booster dose of COVID-19 vaccines could
Israel to reimpose coronavirus 'Green Pass' as Delta variant hits
By Reuters Staff TEL AVIV (Reuters) - Israel announced plans on Thursday to allow only people who are deemed immune to COVID-19 or have recently tested negative to enter some public spaces such as
EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine
By Reuters Staff (Reuters) - Europe's medicines regulator said on Thursday it had added a nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's
China rejects WHO plan for study of COVID-19 origin
By Gabriel Crossley BEIJING (Reuters) - China rejected on Thursday a World Health Organization (WHO) plan for a second phase of an investigation into the origin of the coronavirus, which includes the
UPDATE 1-EU has shipped tiny percentage of planned COVID-19 shot donations - document
(Adding EU's new donation target in 7th and 12th paras) By Francesco Guarascio BRUSSELS (Reuters) - EU countries have so far donated just a tiny portion of excess COVID-19 vaccines to poor nations,
UPDATE 1-UK should be concerned at Chinese gene data harvesting, lawmaker says
(Adds response from BGI in paragraphs 7-8) By Alistair Smout LONDON (Reuters) - The harvesting of genetic data from millions of women by a Chinese company through prenatal tests is concerning and
Organs from deceased recipients of AstraZeneca COVID-19 vaccine may pose problems
By Reuters Staff NEW YORK (Reuters Health) - Organs from deceased donors who had received AstraZeneca's ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 may possibly prompt vaccine-induced thrombosis and
Peru arrests state hospital workers for charging COVID-19 patients $21,000 per bed
By Reuters Staff LIMA (Reuters) - Peruvian police said on Wednesday they had dismantled an alleged criminal ring that had charged as much $21,000 per bed for seriously ill COVID-19 patients in a
Biogen says uptake on new Alzheimers's drug slower than expected
By Manas Mishra and Michael Erman (Reuters) - Biogen Inc on Thursday said getting hospitals and clinics to use its new Alzheimer's disease drug Aduhelm and insurers to reimburse it has been slower
UK should be concerned at Chinese gene data harvesting, lawmaker says
By Alistair Smout LONDON (Reuters) - The harvesting of genetic data from millions of women by a Chinese company through prenatal tests is concerning and Britain should debate how privacy can be
Africa demands local production of COVID vaccines
By Duncan Miriri and George Obulutsa NAIROBI (Reuters) - Global pharmaceutical firms should license production of COVID-19 vaccines in Africa rather than just do piecemeal contract deals, an African
Vietnam in talks with U.S. for local production of COVID-19 mRNA vaccine
By Reuters Staff HANOI (Reuters) - Vietnam is in talks with the United States on domestic production of mRNA vaccines, its foreign ministry said on Thursday, as the country looks to boost supplies
EU has shipped tiny percentage of planned COVID-19 shot donations - document
By Francesco Guarascio BRUSSELS (Reuters) - EU countries have so far donated just a tiny portion of excess COVID-19 vaccines to poor nations, mostly AstraZeneca shots, less than 3% of the 160 million
'Pingdemic' puts Britain's food supply under strain
By Guy Faulconbridge and James Davey LONDON (Reuters) - British supermarkets said on Thursday that some products were in short supply and petrol stations had been forced to close after the official
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds
By Reuters Staff LONDON (Reuters) - Two doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the
1.5 million children lost parents to COVID-19 so far
By Reuters Staff (Reuters) - During the first 14 months of the pandemic, an estimated 1.5 million children worldwide experienced the death of a parent, custodial grandparent, or other relative who
Eflornithine repurposed to treat rare genetic syndrome
By Marilynn Larkin NEW YORK (Reuters Health) - Eflornithine, an FDA-approved drug to treat hirsutism that is being studied in several cancer clinical trials, effectively treated a child with a new
State AGs urge support for landmark $26 bln opioid settlement
By Nate Raymond (Reuters) - A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid
Suicide attempts more common among U.S. Muslims than in other religious groups
By Linda Carroll (Reuters Health) - Muslims in the U.S. are more likely to have attempted suicide than members of other religions, a new study suggests. Survey responses from a weighted sample of
Omega-3 fatty acid EPA tied to lower cardiovascular risk
By Marilynn Larkin NEW YORK (Reuters Health) - Eicosapentaenoic acid (EPA) was associated with improved cardiovascular outcomes and reduced mortality, in a systematic review and meta-analysis of
Combination treatment with dolutegravir non-inferior to darunavir against resistant HIV
By Reuters Staff NEW YORK (Reuters Health) - A 48-week trial conducted in Africa shows treatment with dolutegravir and two nucleoside reverse-transcription inhibitors (NRTIs) is not inferior to a
New York City requires health workers to be vaccinated or get tested weekly
By Maria Caspani NEW YORK (Reuters) - As part of a nationwide response to the threat posed by the more contagious Delta coronavirus variant, New York City will require COVID-19 vaccinations or weekly
Healthcare-related conflicts of interest common among U.S. lawmakers
By Lisa Rapaport (Reuters Health) - More than one-third of U.S. members of Congress have held investments in the healthcare industry in recent years, including members who serve on healthcare-related
'Hands off my natural immunity': French protest against COVID health pass
By Emilie Delwarde and Clotaire Achi PARIS (Reuters) - Hundreds of people protested in Paris on Wednesday against the introduction of a health pass for some activities and against compulsory
Greek police, protesters clash in protest against COVID vaccines
By Reuters Staff ATHENS (Reuters) - Police fired tear gas and water canon to disperse crowds protesting against coronavirus vaccinations in Athens on Wednesday. About 1,500 people took part in the
UPDATE 1-J&J forecasts $2.5 bln in COVID-19 vaccine sales this year
(Adds details on vaccine pricing, background) By Manas Mishra and Carl O'Donnell (Reuters) - Johnson & Johnson on Wednesday forecast $2.5 billion in 2021 sales for its COVID-19 shot and set a lower
Drugmakers, pharmacies next targets for U.S. opioid settlements
By Brendan Pierson NEW YORK (Reuters) - With a $26 billion nationwide settlement in sight over claims that the three largest U.S. drug distributors and Johnson & Johnson helped fuel a nationwide
Polygenic-variant testing can help improves glaucoma-risk prediction
By David Douglas NEW YORK (Reuters Health) - Polygenic risk scores can improve risk stratification in people at increased odds of developing open-angle glaucoma (OAG), according to researchers in
Head CT findings offer window into recovery after concussion
By Reuters Staff NEW YORK (Reuters Health) - Different patterns of brain injury on head computed tomography (CT) correlate with prognosis after mild traumatic brain injury (mTBI), according to a new
Pharmacist in deadly U.S. meningitis outbreak resentenced to 10-1/2 years in prison
By Nate Raymond BOSTON (Reuters) - An ex-pharmacist at a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly fungal meningitis outbreak in 2012 was resentenced on Wednesday to
India reports first human death from bird flu
By Reuters Staff NEW DELHI (Reuters) - An 11-year-old boy has died in India from an infection with the avian H5N1 influenza virus, the first such fatality in the country, highlighting a potential new
J&J forecasts $2.5 bln in COVID-19 vaccine sales this year
By Manas Mishra and Carl O'Donnell (Reuters) - Johnson & Johnson on Wednesday forecast $2.5 billion in sales of its one-shot COVID-19 vaccine this year based on the current price of $5 per dose and
Sinopharm's COVID-19 shot induces weaker antibody responses to Delta -study
By Reuters Staff BEIJING (Reuters) - Sinopharm's COVID-19 vaccine elicited weaker antibody responses against the Delta variant, based on the first published study of its effect against the more
Western wildfire smoke causes cross-country air pollution
By Peter Szekely and Steve Gorman (Reuters) - Wildfires raging across the western United States and Canada, including a "monster" two-week-old blaze in Oregon, on Tuesday belched smoke and soot that
'Feeling Safe' CBT eases persistent persecutory delusions
By Reuters Staff NEW YORK (Reuters Health) - A novel, theoretically driven cognitive behavior therapy (CBT) called the Feeling Safe program led to large reductions in persecutory delusions in a small
Methotrexate use tied to weakened antibody response after first Pfizer-BioNTech vaccine shot
By Reuters Staff NEW YORK (Reuters Health) - The antibody, but not the T-cell, response to the first dose of the Pfizer SARS-CoV-2 vaccine is impaired in patients taking the immunosuppressant
ANALYSIS-Biogen Alzheimer's drug slow to take off as U.S. Medicare wrestles with coverage
By Deena Beasley (Reuters) - U.S. hospitals that were expected to be early adopters of Biogen's Alzheimer's drug have treated only a handful of patients since its early June approval as they wait for
U.S. life expectancy falls to lowest level in almost 20 years due to COVID-19 -CDC
By Dania Nadeem (Reuters) - Life expectancy in the United States fell by a year and a half in 2020 to 77.3 years, the lowest level since 2003, primarily due to the deaths caused by the COVID-19
Teens want sexual health discussions with providers but talks often don't happen
By Marilynn Larkin NEW YORK (Reuters Health) - Most adolescents and their parents say discussions with their provider about sexual and reproductive health (SRH) are important, but such conversations
Common advanced prostate cancer treatments not tied to significant cognitive decline
By Lisa Rapaport (Reuters Health) - Several therapies commonly used to treat men with metastatic castration-resistant prostate cancer don't appear to cause a significant decline in cognitive function,
Transvaginal US may miss Black women who should be tested for endometrial cancer
By Marilynn Larkin NEW YORK (Reuters Health) - Endometrial thickness (ET) as measured by transvaginal ultrasound (TVUS) is an unreliable indicator of a Black woman's need for a biopsy and may
REFILE-Former FDA adviser calls for wider probe into Biogen Alzheimer's drug approval
(Refiles to add Reuters joint participation in event) By Julie Steenhuysen and Deena Beasley (Reuters) - A federal probe of the U.S. Food and Drug Administration's approval of a controversial new
Former FDA adviser calls for wider probe into Biogen Alzheimer's drug approval
By Julie Steenhuysen and Deena Beasley (Reuters) - A federal probe of the U.S. Food and Drug Administration's approval of a controversial new Alzheimer's disease drug should look into why that
Building a better predictive model for progression to kidney failure
By Megan Brooks NEW YORK (Reuters Health) - A new risk equation can accurately estimate the risk of chronic kidney disease (CKD) progressing to end-stage kidney disease (ESKD), the development team
Mental health services for children lacking in many high-income countries
By Linda Carroll (Reuters Health) - One in eight children have mental health disorders requiring treatment, but even in high-income countries most of these children will not have access to services, a
UPDATE 1-Delta variant behind more than 80% of U.S. cases, but vaccines still highly effective - Fauci
(Adds additional comments from Senate hearing, background) By Carl O'Donnell and Mrinalika Roy (Reuters) - The Delta variant of the coronavirus is the cause of more than 80% of new U.S. COVID-19 cases
Delta variant behind more than 80% of U.S. cases, but vaccines still highly effective - Fauci
By Reuters Staff (Reuters) - The Delta variant of COVID-19 is the cause of more than 80% of the new cases in the United States, but the authorized COVID-19 vaccines in the country are still more than
EU begins real-time review of Sanofi-GSK COVID-19 vaccine
By Reuters Staff (Reuters) - Europe's drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and Britain's GlaxoSmithKline, the
Knee-deep in sewage: German rescuers race to avert health emergency in flood areas
By Ann-Kathrin Weis and Andi Kranz AHRWEILER, Germany (Reuters) - Red Cross volunteers and emergency services in Germany deployed emergency stand-pipes and mobile vaccination vans to flood-devastated
Olympics-Athletes' village COVID-19 isolation bubble already 'broken' - health expert
By Rocky Swift TOKYO (Reuters) - The isolation bubble system that Olympic organisers have set up at the Tokyo Games village to control COVID-19 is already broken, and there is a risk that infections
Drug distributors settle New York opioid claims for up to $1.18 bln
By Brendan Pierson and Nate Raymond NEW YORK (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest
Ficlatuzumab plus chemo shows early promise in refractory AML
By Megan Brooks NEW YORK (Reuters Health) - The combination of ficlatuzumab plus chemotherapy showed considerable early promise in relapsed/refractory acute myeloid leukemia (AML) in a small phase-1
New antiviral drug promising against HBV
By Reuters Staff NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection,
New drug delivery system promises more-targeted delivery of IBD drugs
By Reuters Staff NEW YORK (Reuters Health) - Researchers at Progenity, Inc, in San Diego, California, are developing a new way to deliver drugs for inflammatory bowel disease (IBD) directly to the
Apixaban has benefits over other DOACs in frail adults with atrial fibrillation
By Megan Brooks NEW YORK (Reuters Health) - For frail older adults with atrial fibrillation (AF), apixaban has benefits over other direct oral anticoagulants (DOACs) and warfarin, a new analysis
FACTBOX-Countries make COVID-19 vaccines mandatory
By Reuters Staff (Reuters) - A sharp upturn in new coronavirus infections due to the highly contagious Delta variant and a slowdown in vaccination rates have pushed governments to make COVID-19 jabs
FOCUS-Global quest underway to speed COVID-19 vaccine trials
By Julie Steenhuysen and Ludwig Burger CHICAGO (Reuters) - Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to
Two-thirds of Indians have coronavirus antibodies, survey shows
By Reuters Staff (Reuters) - Two-thirds of India's population have antibodies against the coronavirus, according to data released on Tuesday from a survey of 29,000 people across the nation conducted
India's excess deaths during pandemic up to 4.9 mln - study
By Ankur Banerjee and Neha Arora (Reuters) - India's excess deaths during the COVID-19 pandemic could be as high as 4.9 million, a new study suggests, providing further evidence that millions more may
